Synthomer (LON:SYNT – Get Free Report)‘s stock had its “equal weight” rating reaffirmed by equities research analysts at Barclays in a note issued to investors on Friday, MarketBeat reports. They currently have a GBX 187 ($2.36) price objective on the stock. Barclays‘s price objective indicates a potential upside of 293.52% from the stock’s previous close.
Several other research analysts have also recently weighed in on SYNT. Berenberg Bank reiterated a “buy” rating and set a GBX 225 ($2.84) price target on shares of Synthomer in a research report on Thursday, July 20th. Peel Hunt reissued an “add” rating and issued a GBX 185 ($2.34) price objective on shares of Synthomer in a report on Tuesday, May 16th. Three analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of GBX 216.40 ($2.73).
Check Out Our Latest Report on Synthomer
Synthomer Stock Up 5.6 %
Insiders Place Their Bets
In other Synthomer news, insider Michael Willome bought 55,500 shares of Synthomer stock in a transaction on Thursday, June 22nd. The shares were bought at an average price of GBX 72 ($0.91) per share, for a total transaction of £39,960 ($50,467.29). 27.81% of the stock is currently owned by corporate insiders.
About Synthomer
Synthomer plc operates as a specialty chemicals company in the United Kingdom and internationally. It operates through five segments: Performance Elastomers, Functional Solutions, Industrial Specialities, Acrylate Monomers, and Adhesive Technologies. The company offers adhesives, including PSA labels, packaging and specialty tapes, saturants, release coatings, wood working, wet glues, hygiene and contact adhesives, packaging and assembly hot melt adhesives; coatings products such as architectural, masonry, intumescent, metal, wood, soil releases, blinders, ink receptive, polyester for powder coatings, SYNTHOMER NX for coalescing agents, and SYNOLOX BEPF for glycol.
Recommended Stories
- Five stocks we like better than Synthomer
- Why is the Ex-Dividend Date Significant to Investors?
- MarketBeat Week in Review – 9/4 – 9/8
- Investing In Preferred Stock vs. Common Stock
- The Best 5 Small Cap AI Companies to Buy Now
- What is the Australian Securities Exchange (ASX)
- Miso Robotics Stock: Is an IPO Coming Soon?
Receive News & Ratings for Synthomer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synthomer and related companies with MarketBeat.com's FREE daily email newsletter.